Will integrin inhibitors have proangiogenic effects in the clinic?
Nat Med
.
2009 Jul;15(7):726; author reply 727.
doi: 10.1038/nm0709-726.
Authors
Michael Weller
,
David Reardon
,
Burt Nabors
,
Roger Stupp
PMID:
19584855
DOI:
10.1038/nm0709-726
No abstract available
Publication types
Kommentar
Letter
MeSH terms
Animals
Glioblastoma / drug therapy
Humans
Integrins / antagonists & inhibitors*
Neovascularization, Pathologic / chemically induced*
Snake Venoms / adverse effects*
Substances
Integrins
Snake Venoms
Cilengitide
Grants and funding
BREAST CANCER NOW RESEARCH CENTRE/BCN_/Breast Cancer Now/United Kingdom